SEC Form 4 · accession 0000891293-15-000062

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Corporate Development

Period of report

Dec 4, 2015

Accepted (ET)

Dec 4, 2015 · 6:30 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Dec 4, 2015	S	1,500	$0.9901	D	628,584	D
Common Stock	Dec 4, 2015	S	600	$0.9902	D	627,984	D
Common Stock	Dec 4, 2015	S	200	$0.9924	D	627,784	D
Common Stock	Dec 4, 2015	S	200	$0.9935	D	627,584	D
Common Stock	Dec 4, 2015	S	1,100	$0.9947	D	626,484	D
Common Stock	Dec 4, 2015	S	200	$0.9948	D	626,284	D
Common Stock	Dec 4, 2015	S	600	$0.995	D	625,684	D
Common Stock	Dec 4, 2015	S	100	$0.9975	D	625,584	D
Common Stock	Dec 4, 2015	S	100	$0.9995	D	625,484	D
Common Stock	Dec 4, 2015	S	300	$0.9996	D	625,184	D
Common Stock	Dec 4, 2015	S	200	$0.9998	D	624,984	D
Common Stock	Dec 4, 2015	S	100	$0.9999	D	624,884	D
Common Stock	Dec 4, 2015	S	4,500	$1.00	D	620,384	D
Common Stock	Dec 4, 2015	S	100	$1.005	D	620,284	D
Common Stock	Dec 4, 2015	S	200	$1.01	D	620,084	D

No Table II lines on this filing.